Executive Director, Medical Evidence Generation Cell Therapy, Global Medical Affairs

Working with Us
Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

The Executive Director, Cell Therapy, Medical Evidence Generation (MEG - Global Medical Affairs) will lead the development and implementation of evidence generation book of work (including Medical Affairs Sponsored studies, clinical research collaborations, investigator-sponsored studies and select health outcomes studies) associated with the Cell Therapy portfolio/pipeline and provides leadership for the respective MEG Team. In this role, he/she will oversee the development of the Integrated Evidence Plans (IEPs) and will be responsible for the prioritization, development, review, and execution of all evidence-generation activities to unlock the value for patients, healthcare providers and the business. He/She will report to the Head of Medical Evidence Generation and Managed Access Programs.

The incumbent will apply an enterprise mindset and lead strategically across the BMS matrix by working with stakeholders from Global Medical and International Medical Teams, Research & Discovery, Global Drug Development (GDD), Health Economics & Outcomes Research (HEOR), Global Biometric and Data Sciences (GBDS), Regulatory, Pharmacovigilance and other key functions to align on highest priority areas and evidence gaps, review proposals, and execution of approved studies and collaboration agreements.

Key Responsibilities

• Strategic Planning: Develop the 3-year strategic MEG plan for Cell Therapy and provide oversight of this portfolio of studies and thought partnership on trade-offs across studies to the worldwide TA (WWTA) and HEOR partners.
• Integrated Evidence Planning: Drive the development and maintenance of the IEPs for the Cell Therapy assets/indications, that align with unmet medical needs and business priorities, in partnership with WWTA teams, HEOR, GDD and other key internal stakeholders.
• Portfolio Leadership: Overall end-to-end responsibility for the medical oversight of Cell Therapy MEG book of work (Medical Affairs sponsored studies, clinical research collaborations and investigator-sponsored studies) ensuring they are on strategy and executed with rigor and on time.
• Collaboration/Matrix Leadership: Serve as a matrix partner with CT Leadership Team, Global Medical and International Medical teams. Facilitate Medical governance through the TAG forum and support MEG leads in executing EGWG meetings.
• Innovation and Data Driven Decision Making: Foster an innovative culture and lead initiatives to increase innovative approaches to evidence generation and lead with business savviness to leverage data analytics to define value drivers that will drive data-driven decisions.
• Portfolio Execution: Provide scientific oversight and clinical decision-making responsibility for studies within remit, inclusive of the conception, writing and monitoring of BMS-sponsored, medically-led research studies and ensure their timely accrual and completion. Ensure fiscal responsibility by maintaining a balanced budget for MEG Book of Work (BOW).
• Chair the Review Committees or contribute during the approval process for final protocols, amendments, and budgets for studies under remit.
• Serve as the subject matter expert on the current book of work for studies under remit and give updates to senior leadership/key stakeholders across the organization.
• Skillful Leadership: Lead and mentor a team of MEG Leads, Clinical Scientists, Clinical Trial Physicians and project managers to ensure strategic and rigorous execution of all scientific aspects associated with evidence generation activities.
• External Engagement: Serve as a trusted expert in meetings with investigators, external stakeholders and cross-functional internal teams involved in studies under remit to discuss scientific rationale and expected impact, challenges associated with execution, budget concerns, and/or data readouts.

Qualifications & Experience

• Advanced scientific degree (e.g. Pharm.D., MD, PhD) with 10+ years of experience; 5+ years clinical trial expertise with a mix of development/clinical and medical with an emphasis on conduct/execution of trials.
• Formal specialization in areas associated with the current cell therapy portfolio and/or professional experience with assets in this space is preferred.
• Cross-Functional Alignment & Influence: Proven ability to align across diverse teams and influence stakeholders toward shared success.
• Outcome-Driven Execution: Demonstrated capability to drive initiatives beyond effectiveness, ensuring measurable impact and results.
• Matrix Team Leadership: Experience leading high-performing matrixed teams to deliver strategic outcomes and organizational impact.
• People Management Excellence: Strong track record of managing and developing talent with a focus on performance, engagement, and growth.
• Entrepreneurial Mindset: Ability to anticipate market dynamics and identify opportunities to accelerate pipeline development.
• The successful candidate should have strong analytical skills, strong scientific data and evidence interpretation + contextualization and ability to work effectively with cross-functional teams including clinical, commercialization, regulatory, HEOR and Access.
• Entrepreneurial thinking, anticipates needs, assesses and manages business and organizational risks.
• Highly organized and motivated and possess excellent people management, interpersonal, and strong communication skills.
• HQ based position with international/domestic travel requirement approximately 20%.

Compensation Overview:
$254,530 - $308,434
The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee's work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience.